数据日期 2026-10-29 · 生成时间 2026-10-29 06:03
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
Parkin plays a pivotal role in the pathogenesis of Parkinson's disease (PD).
方法
In this study, we demonstrated that OTUD1 expression was significantly elevated in the nigrostriatal region of PD patients and MPTP-induced PD mice.
核心结论
Although ovarian tumor protease deubiquitinase 1 (OTUD1) participates in various biological processes, its specific functions in PD and its regulation of Parkin remain unclear.；Genetic ablation of OTUD1 markedly improved motor deficits and attenuated dopaminergic neuronal loss in PD models.；Mechanistically, OTUD1 worsened mitochondrial dysfunction in PD models by negatively regulating Parkin protein levels. ‖ 结论：Our findings identify OTUD1 as a negative regulator of Parkin and reveal a mechanism linking deubiquitination to mitochondrial dysfunction in PD, which offers a novel potential therapeutic target for PD.
局限
未能获取全文，具体设计细节、失访与统计学处理无法核验。
对本项目的价值
★★★☆☆ 脑老化是最大未满足需求，也是终点最难量化的领域；biomarker 与认知读数选择最敏感。
原文题录
- 英文标题：The deubiquitinase OTUD1 aggravated dopaminergic neurodegeneration in Parkinson's disease model by promoting the degradation of Parkin.
- 期刊与标识：Exp Neurol · PMID 42946036 · DOI 10.1016/j.expneurol.2026.116080**
A 级证据分级：A 级（同行评议人体研究）
本文属人体研究证据，但需注意：观察性或小样本干预的结论不等于已证实临床获益；效应量与长期安全性仍需更大规模、更长随访的试验验证。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。